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ABSTRACT 
The specific effect of oxygen and reactive oxygen species (ROS) in mediating post-
translational modification of protein targets has emerged as a key mechanism regulating 
signaling components, a process termed redox signaling. ROS act in the post-translational 
modification of multiple target proteins including receptors, kinases, phosphatases, ion 
channels and transcription factors. Both O2 and ROS are major source of electrons in redox 
reactions in aerobic organisms. Because the heart has the highest O2 consumption among 
body organs, it is not surprising that redox signaling is central to heart function and 
pathophysiology. In this article, we review some of the main cardiac redox signaling 
pathways and their roles in the cardiomyocyte and in heart failure, with particular focus on 
the specific molecular targets of ROS in the heart. 
 
SIGNALLING NETWORK FACTS: 
 The view that ROS are either harmful or beneficial is very simplistic. ROS can 
mediate specific post-translational modifications of biomolecules involved in 
intracellular signaling networks.  
 Redox signaling typically involves spatially and temporally confined ROS 
production by specific sources of ROS, which can amplify or inhibit the activity of 
signaling network components.  
 The NADPH oxidase proteins Nox2 and Nox4 are major enzymatic sources of ROS 
involved in cell signaling in cardiomyocytes.  
 Redox signaling is involved in acute and chronic cardiac adaptations to diverse 
stresses and several molecular targets have been identified that are redox-
modified in these settings. 
 
Abbreviations: AKAP, A-kinase anchoring protein; CaMKII, Ca2+/calmodulin-dependent 
kinase II; ECC, excitation contraction coupling; eIF2α, eukaryotic initiation factor 2α ER, 
endoplasmic reticulum; ETC, electron transport chain; GPCR, G-protein coupled receptor; 
3 
 
Hif1, hypoxia-inducible factor 1; HDAC, histone deacetylase; MEF2, myocyte enhancer fator-
2; Nox, NADPH oxidase; NO, nitric oxide; NOS, nitric oxide synthase; Nrf2, nuclear factor 
erythroid-derived 2-like 2; PHD, prolyl hydroxylase; PKA, protein kinase A; PKG, protein 
kinase G; PLN, phospholamban; PP1, protein phosphatase 1; ROS, reactive oxygen species; 
RyR, Ryanodine receptor; SERCA, sarcoplasmic reticulum Ca2+ ATPase; SR, sarcoplasmic 
reticulum; Trx, thioredoxin  
 
Keywords: Redox signaling; NADPH oxidase; heart failure; reactive oxygen species 
 
1. Introduction  
 At a time of unprecedented subatomic detail in physics (e.g. the Higgs' boson), it is 
notable that the chemistry that underpins multi-cellular living systems is the chemistry of 
the electron. Coupled electron flow involving electron acceptors (e.g. NAD+/NADP+ and 
FAD+/FADP+) and electron donors (e.g. NADH/NADPH and FADH/FADPH) is involved in 
fundamental cellular processes such as the electron transport chain (ETC) of the 
mitochondria, protein folding in the endoplasmic reticulum (ER) and many metabolic 
processes. While there are several primary sources of electrons, the main sources of 
electrons for redox reactions in aerobic organisms are O2 itself and O2-derived reactive 
species (ROS), because of their abundance and specific chemical proprieties. Perhaps the 
most abundant O2-derived ROS is superoxide (O2–), which may be  generated from partial 
one-electron reduction during electron leak in the mitochondrial ETC as well as by the 
enzymatic action of several specific oxidases such as NAPDH oxidases (Lassègue et al., 2012), 
xanthine oxidase (Minhas et al., 2006) and monoamine oxidases (Kaludercic et al., 2010). As 
a free radical, O2– reacts with itself to produce the more stable hydrogen peroxide (H2O2) in 
a reaction that is enhanced many fold by superoxide dismutases. H2O2 is a non-radical that 
can be decomposed by catalase or by oxidizing enzymes such as peroxidases but is also an 
important oxidizing agent of many organic molecules (e.g. protein cysteine and methionine 
residues and metalloproteins - see below). O2 is used by nitric oxide synthases (NOSs) to 
generate nitric oxide (NO), a reactive nitrogen species (RNS) that is also involved in cell 
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signaling. NO is a precursor of other reactive species, such as ONOO− (formed by reaction 
with O2–) and ONOOCO2− (formed in the presence of CO2/HCO3) (Augusto et al., 2002). 
 It has become evident that redox reactions have a key role in cell signaling pathways 
in addition to their involvement in cellular metabolic and biosynthetic processes. The 
specific compartmentalized generation of ROS - in particular, H2O2 - modulates many cell 
signaling pathways, a process known as redox signaling. ROS act through post-translational 
modification of numerous types of biomolecules, particularly proteins such as receptors, 
kinases, phosphatases, caspases, ion channels and transcription factors. A wide range of 
redox modifications may be involved in redox signaling, among which the most studied is 
the H2O2-mediated oxidation of cysteine (Cys) residues in proteins. Protein Cys residues with 
low pKa are susceptible to oxidation to form usually reversible intra- or inter-molecular 
disulfides (Wouters et al., 2011; Rudyk and Eaton, 2014). ROS-mediated thiol oxidation may 
modulate the activity of enzymes in which Cys moieties are critical, e.g. by affecting 
substrate binding in glyceraldehyde 3-phosphate dehydrogenase (Peralta et al., 2015) and 
many tyrosine phosphatases (Finkel 2011). Cys oxidation may also result in other 
intermediates, e.g. adducts of Cys with NO (nitrosylation), nitroxyl (HNO; Sivakumaran et al., 
2013), or glutathione (glutathiolation) (Rudyk and Eaton, 2014). It is important to note that 
the effects of ROS are greatly affected by the local anti-oxidant environment. In this regard, 
glutathione is a major cellular antioxidant that can reduce a wide range of oxidized proteins. 
The thioredoxin system may have more specific reductive and signaling functions, as 
discussed in section 3.5. 
 
2. Functions 
2.1 Redox signaling in the heart 
 The beating heart has the highest O2 consumption of all organs and this can rise 
several-fold in response to increased workload. Perhaps not surprisingly, along with altered 
O2 metabolism, ROS generation and redox signaling are also involved in the cardiac 
adaptations to different types of physiological and pathological stress (Santos et al., 2011). 
The heart exhibits acute adaptations in its contractile performance but is also able to 
chronically remodel its structure and function in the face of prolonged alterations in 
workload. A virtually universal component of chronic cardiac remodeling is an increase in 
size of individual cardiomyocytes and the ventricular wall (termed cardiac hypertrophy), 
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while sustained disease stress may lead to irreversible structural and contractile dysfunction 
(i.e. heart failure). Redox signaling pathways play important roles both in acute cardiac 
adaptations and in chronic cardiac remodeling leading to heart failure (Shah and Mann, 
2013). In this article, we summarize current knowledge on the key intracellular molecular 
targets of redox regulation involved in heart failure. The role of NO and RNS has been 
reviewed elsewhere (Simon et al., 2014).  
 
2.2 Main sources of ROS in cardiomyocytes 
Mitochondria, NADPH oxidases (Noxs), uncoupled NO synthases, xanthine oxidase and 
monoamine oxidases are among the main ROS sources in the heart (Burgoyne et al., 2012). 
Mitochondria can generate ROS at different steps during O2 reduction to H2O in the ETC. 
This may be especially important in the setting of ischemia-reperfusion, where ROS 
generation upon reperfusion was recently shown to be driven by the oxidation of 
accumulated succinate and consequent reverse electron transport at complex 1 (Chouchani 
et al., 2014). An additional source of mitochondrial ROS are the monoamine oxidases, which 
have been implicated in heart failure (Kaludercic et al., 2010; Kaludercic et al., 2014).   
Noxs are a family of enzymes that specifically generate ROS as their primary function 
and have emerged as the major cellular ROS sources involved in redox signaling (Lassègue et 
al., 2012). Noxs use NADPH as an electron donor to reduce O2 to O2–/ H2O2 and appear well 
suited for involvement in redox signaling because (i) they can be specifically activated or 
expressed by diverse agonists (e.g. G-protein coupled receptor [GPCR] agonists such as 
angiotensin II) or in specific stress conditions (e.g. hypoxia); (ii) they generate ROS in distinct 
sub-cellular locations; (iii) they may be co-located with specific signaling targets. Seven Nox 
isoforms (Nox1-5, Dual oxidase1-2) have been identified, each with a distinct catalytic 
subunit responsible for oxidase activity and with varying requirements for other accessory 
subunits. Among these, the Nox2 and Nox4 isoforms are expressed in cardiomyocytes. Both 
isoforms are transmembrane heterodimers bound to a smaller p22phox subunit but they 
differ significantly in their sub-cellular location, activation and regulation. Nox2 is located at 
the sarcolemma and in t-tubules. It requires acute activation by agonists (e.g. angiotensin II, 
mechanical forces) in a complex process that involves the post-translation modification of 
regulatory subunits (p47phox, p67phox, p40phox, Rac1) and their association with the Nox2-
p22phox heterodimer to form the fully activated enzyme. By contrast, Nox4 is found in the 
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endoplasmic reticulum (sarcoplasmic reticulum [SR] in cardiomyocytes) and possibly the 
mitochondria. Intriguingly, a splice variant of Nox4, termed Nox4D, is located in the nucleus 
(Anilkumar et al., 2013). Nox4 is constitutively active (i.e., does not require acute activation) 
and is thought to be regulated predominantly by its abundance and location. Nox2 and Nox4 
have distinct and often contrasting effects in the pathophysiology of heart failure (Burgoyne 
et al., 2012). Detailed reviews of the regulation of Noxs and their roles in the cardiovascular 
system have been published recently (Lassègue et al., 2012; Brandes et al., 2014).  
 
3. Cascades and Key Molecules 
Several different molecular targets of redox regulation in heart failure have been identified. 
Here we consider the key targets for which molecular mechanisms of redox modulation 
have been identified (Fig. 1). 
 
3.1 Ca2+/calmodulin-dependent kinase II (CaMKII).  
CaMKII is a multifunctional kinase present as γ, β or δ isoforms.  The transient activation of 
CaMKII-δ in cardiomyocytes has been implicated in physiological β-adrenergic agonist-
induced increases in heart rate and contractility. However, sustained CaMKII activation may 
be detrimental via effects on excitation-contraction coupling (ECC) and cell death, and may 
contribute to heart failure (Luczak et al., 2014). CaMKII is a supramolecular complex formed 
of 12 monomers assembled as hexamers, with each monomer having catalytic, auto-
inhibitory and Ca/calmodulin-binding domains. Under resting conditions the auto-inhibitory 
domain mimics substrate binding to the catalytic domain and blocks kinase activity. The 
binding of Ca2+ to the Ca/calmodulin domain induces auto-phosphorylation and disrupts the 
auto-inhibitory domain to expose the catalytic site and maintain the enzyme functional even 
when Ca2+ levels decline. The Anderson laboratory found that following initial Ca-dependent 
activation of CamKII, the specific oxidation of conserved Met 281/282 residues in the 
regulatory domain could increase CaMKII activity independent of Ca/calmodulin (Erickson et 
al., 2008). Furthermore, the Met oxidation could be reversed by methionine sulfoxide 
reductase A, supporting a physiological role for this modification. CaMKII can through this 
mechanism therefore integrate two key signaling molecules, namely Ca2+ and ROS. Studies 
in gene-modified mice showed that CaMKII oxidation contributes to an increase in 
cardiomyocyte death and the development of heart failure after myocardial infarction or 
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chronic angiotensin II stresss (Erickson et al., 2008). Subsequent studies have confirmed a 
role of increased CaMKII oxidation in several cardiac stress situations (Wagner et al., 2006, Li 
et al., 2012; Purohit et al., 2013).  
 Nox2 was found to be the upstream mediator of CaMKII oxidation during chronic 
neurohumoral stress, with mice deficient in Nox2 oxidase activity showing reduced 
cardiomyocyte apoptosis and heart failure in models of chronic angiotensin II infusion and 
myocardial infarction (Erickson et al., 2008). Nox2 was also linked to CaMKII activation in a 
model of endoplasmic reticulum stress-induced cardiac dysfunction (Roe and Ren, 2013) 
and in a cellular model of angiotensin II-induced arrhythmia (Wagner et al., 2014). On the 
other hand, in a mouse model of streptozotocin-induced diabetes, cardiac bradycardia 
following myocardial infarction was related to increased mitochondrial-derived ROS and 
hyperactivity of oxidised CaMKII (Luo et al., 2013). Therefore, it appears that different ROS 
sources can link to CaMKII oxidation depending on the context. More recently, it has been 
reported that an increase in CaMKII activity can be induced via O-GlcNAc-modification at 
Ser 279, which similar to the oxidized phenotype exhibits molecular memory in that enzyme 
activity is maintained even after a decline in Ca2+ concentration (Erickson et al., 2013). The 
latter modification was linked to cardiac arrhythmia in the diabetic heart.  
 
3.2 cGMP-dependent protein kinase (PKG). 
PKG is a cytosolic protein that forms a homodimer of two identical subunits folded together 
by a leucine zipper interaction at the N-terminal, a site that determines PKG interaction to 
substrates (G-Kinase anchoring proteins). The binding of cGMP to a regulatory domain 
exposes the catalytic domain and kinase activity. In cardiac cells, PKG type 1 has at least 5 
Cys residues that can be oxidized. The oxidation of Cys42 results in an inter-disulfide 
between the two monomers which activates the kinase independently of the NO-cGMP 
pathway (Burgoyne et al., 2007). The Eaton laboratory developed a "redox-dead" PKG1C42S 
knock-in mouse model and found that these animals developed modest hypertension, 
suggesting that PKG oxidation and resulting vasodilation may be involved in the 
physiological regulation of blood pressure (Prysyazhna et al., 2012). Increased PKG activity 
has generally been reported to be cardioprotective in response to hemodynamic stresses 
and, therefore, in contrast to oxidation-induced increases in CaMKII and PKA activity (see 
later), it might be anticipated that PKG oxidation might be beneficial during heart failure. 
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However, it was recently found that “redox-dead" PKG1C42S knock-in mice (in which PKG 
oxidation is inhibited) were actually relatively protected against the development of 
hemodynamic stress-induced heart failure (Nakamura et al., 2015). It was suggested that 
PKG1 oxidation during hemodynamic stress leads to failure of translocation of the enzyme 
to the sarcolemma where it normally mediates anti-hypertrophic signaling by inhibiting 
transient receptor potential channel 6 (TRPC6) (Nakamura et al., 2015). The ROS sources 
responsible for PKG oxidation are yet to be determined. These results suggest that the 
modification of substrate binding (and therefore subcellular location) subsequent to change 
in PKG1 redox state is as important as changes in activity per se. The maintenance of PKG in 
a reduced state during chronic hemodynamic stress therefore appears to be beneficial.  
 
3.3 cAMP-dependent protein kinase (PKA). 
β-adrenergic stimulation stimulates adenylate cyclase to increase intracellular cAMP levels 
and activate PKA, which in turn phosphorylates several important proteins involved in ECC 
(e.g. the L-type Ca channel, phospholamban and troponin I). As such, PKA is a central 
regulator of cardiac contractility. Furthermore, altered PKA activity is involved in the 
pathophysiology of heart failure. PKA is a hetero-tetramer with a regulatory subunit dimer 
and a catalytic subunit dimer. It was found that PKA oxidation resulting in the formation of 
an inter-disulfide bond between the two regulatory subunits activates the enzyme 
independently of cAMP (Brennan et al., 2006). Furthermore, this modification increases the 
affinity for A-kinase anchoring proteins (AKAPs) which targets the kinase to its substrates, 
thereby causing PKA translocation. Recently, it was shown with the use of a novel mouse 
model in which PKA is "redox-dead" due to a Cys175Ser mutation in the R subunit, that this 
disrupted PKA-dependent VEGF/ERK signaling (Burgoyne et al., 2015). The functional 
consequence of PKA oxidation was found to be an enhancement of angiogenesis in models 
of hind-limb ischemia and tumor angiogenesis, and this work suggested that Nox4 may be 
upstream of PKA oxidation. It will be of interest in future studies to establish what role(s) 
PKA oxidation may play in heart physiological function and failure, and what ROS sources 
are involved.   
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3.4 Proteins involved in Excitation Contraction Coupling (ECC). 
During cardiomyocyte ECC, initial influx of Ca2+ through sarcolemmal L-type Ca2+ channels 
following membrane depolarization induces the opening of ryanodine receptor (RyR) 
channels in the SR and Ca2+ release into cytoplasm (Ca-induced Ca-release) to promote 
contraction upon the binding of Ca2+ to troponin C. Muscle relaxation is promoted by the re-
uptake of Ca2+ into the SR via the SR Ca2+-ATPase pump (SERCA) and Ca2+ efflux from the cell 
via the Na+/Ca2+ exchanger. The affinity of SERCA for Ca2+ is regulated by its interaction with 
phospholamban (PLN) (Kranias and Hajjar, 2012). In addition to the fundamental 
physiological role of ECC in mediating acute changes in heart contractile performance, 
abnormalities of ECC are a key pathogenic feature of heart failure (Kohler et. al., 2014). 
Many key proteins involved in ECC, e.g. the L-type Ca channel, RyR, SERCA, PLN and 
troponin I, are regulated by phosphorylation by PKA, CaMKII or PKG and may therefore be 
indirect targets of redox signaling (Fig. 2). Recently, we found an indirect redox modulation 
of SERCA activity mediated via Nox2 (Zhang et al., 2015). In hearts overexpressing Nox2, 
SERCA activity and contractile performance were increased as a result of an increase in PLN 
phosphorylation. This increase in PLN phosphorylation was associated with a decrease in 
activity of the Ser/Thr protein phosphatase-1 (PP1), which normally dephosphorylates PLN. 
This finding highlights the fact that redox regulation of phosphorylation may occur 
secondary to reduced phosphatase activity as well as changes in kinase activity. 
Some proteins involved in ECC, such as RyR and SERCA, are also direct targets of 
ROS. The RyR structure was recently resolved by electron microscopy and comprises a 
tetrameric complex (Zalk et al., 2015). Each subunit has around 20 free Cys residues that can 
be subject to various redox modifications. It was recently shown that mechanical stretch of 
cardiomyocytes induces cyclical activation of Nox2 in t-tubules and leads to an 
augmentation of RyR Ca2+ release (Ca2+ sparks), thereby contributing to a fundamentally 
important physiological pathway for stretch-induced augmentation of cardiac output 
(Prosser et al., 2011; Prosser et al., 2013). At a molecular level, this is likely to be mediated 
by reversible oxidation of the RyR although this was not definitively demonstrated in this 
study. In pathological settings, more extensive/sustained and often irreversible oxidation or 
hyper-nitrosylation of the RyR contributes to Ca2+ leak from the SR, with consequent 
increase in arrhythmia and contractile dysfunction (Simon et al., 2014). The precise ROS 
sources that may be involved in RyR oxidation in heart failure remain unclear. Mitochondria 
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are likely to be an important source while Nox2 is also implicated in models of muscular 
dystrophy (Prosser et al., 2011). In skeletal muscle, it was reported that Nox4 can oxidize 
RyR1 and lead to increased Ca2 leak during hypoxia (Sun et al., 2011). Whether Nox4 has 
similar effects in cardiac myocytes is not known. 
SERCA activity is also redox modulated. In vascular smooth muscle, the reversible 
glutathionylation of Cys674 increases SERCA activity and induces vasorelaxation 
independent of NO-cGMP (Adachi et al., 2004). Physiological redox regulation of SERCA in 
the heart remains to be definitively established. However, SERCA2 activity may be enhanced 
by HNO-induced oligomerization of PLN, which reduces the amount of inhibitory monomeric 
PLN (Sivakumaran et al., 2013). Irreversible oxidation of cardiac muscle SERCA in disease 
settings such as hemodynamic overload and chronic neurohumoral activation impairs 
activity and causes contractile dysfunction (Lancel et al., 2010; Qin et al., 2014).  
 
3.5 Molecules involved in cardiac hypertrophy and remodeling. 
The redox-sensitive modulation of the small G protein Ras, kinases such as ERK1/2, 
p38MAPK, protein kinase C and Akt, and transcription factors such as AP-1 and NF-B, is 
well established in many different body systems and is not considered in detail here. 
However, it has been found that Nox2-dependent activation of ERK1/2 and Akt contribute 
to the development of GPCR agonist-induced cardiac hypertrophy. (Bendall et al., 2002; 
Satoh et al., 2006; Burgoyne et al., 2012)  The redox activation of apoptosis signaling kinase-
1 and p38MAPK/JNK (most likely via Nox2) contributes to cardiomyocyte cell death and 
detrimental ventricular remodeling in heart failure (Yamaguchi et al., 2003). 
Thioredoxin (Trx) is an important molecule that mediates the redox shuffling of 
protein thiols in different cell compartments (Trx1 in the cytoplasm and Trx2 in the 
mitochondria). Trx has a conserved motif of two vicinal Cys which can form an 
intramolecular disulfide bond. Trx reduces oxidized thiols in target proteins, typically via 
specific protein-protein interaction, and itself becomes oxidized in the process. The oxidized 
Trx is reduced back by thioredioxin reductase in an NADPH and FAD-dependent reaction. 
The Trxs and peroxiredoxins (which react avidly with H2O2) may function as redox relays for 
the transmission of H2O2 signals, e.g. in the regulation of transcription factors (Jarvis et al., 
2012; Sobotta et al., 2015). Dysfunctional Trx1 and Trx2 are implicated in increased cardiac 
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ROS production and cardiac remodeling, while overexpression of Trx1 attenuated pressure 
overload-induced cardiac hypertrophy (Yamamoto et al., 2003; Stanley et al., 2011). 
Another molecular target of redox regulation during cardiac hypertrophy is the Class 
II histone deacetylase, HDAC4, which is known to be important in inhibiting the expression 
of pro-hypertrophic genes induced by the transcription factor myocyte enhancer fator-2 
(MEF2). HDAC4 phosphorylation promotes its export from the nucleus, thereby facilitating 
hypertrophic gene expression. Ago et al. (Ago et al., 2008) showed that phosphorylation-
independent nuclear export of HDAC4 and induction of hypertrophy resulted from specific 
Trx1-sensitive HDAC4 oxidation (intramolecular disulfide formation between Cys-667 and 
Cys-669) during α-adrenoceptor stimulation (Fig. 1). Nox4 was reported to be a ROS source 
that mediates HDAC4 oxidation and cardiac hypertrophy (Matsushima et al., 2013). 
Isoproterenol-induced export of HDAC5 from the cardiomyocyte nucleus was also reported 
to be mediated by oxidation (Haworth et al., 2012). Class II HDACs are phosphorylated by 
CaMKII or PKA during heart failure (Backs et al., 2001) and therefore can also be an indirect 
target of redox regulation (Fig. 1). Taken together, these data highlight the potential for 
redox regulation to add a layer of complexity that fine tunes the normal epigenetic 
regulation modulated by phosphorylation and acetylation. 
 
3.6 Molecules involved in other cardiac stress responses. 
Prolyl hydroxylases (PHDs) are enzymes that use O2 to hydroxylate proline residues in 
proteins. Proline hydroxylation of the transcription factor Hif1 (hypoxia-inducible factor 1) is 
a major mechanism that regulates Hif stability by promoting its proteosomal degradation. In 
the heart, Hif1 is induced by hypoxia and chronic hemodynamic overload and drives 
diverse gene programs, e.g. the promotion of angiogenesis. It has been shown that Hif1-
VEGF signaling is important in driving coordinated heart hypertrophy and angiogenesis that 
promotes preservation of cardiac function during chronic pressure overload (Shiojima et al., 
2005; Sano et al., 2007). Hypoxia as well as ROS can inhibit PHDs and thereby stimulate 
Hif1-VEGF signaling (Lee and Simon, 2015). Nox4 expression is upregulated by hypoxia and 
chronic hemodynamic overload and studies in gene-modified mouse models showed that 
Nox4 is protective against cardiac decompensation during hemodynamic overload (Zhang et 
al., 2010). We found that this protection was related to an enhanced Hif1 activation and 
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release of VEGF from cardiomyocytes (most likely due to PHD inhibition), resulting in 
paracrine angiogenic activity that facilitated the preservation of myocardial capillary density 
during pressure overload (Zhang et al., 2010). A similar Nox4-dependent activation of Hif1 
has been demonstrated in the setting of cardiac ischemia (Matsushima et al., 2013) but 
mitochondrial ROS can also activate Hif1 (Chandel et al., 1998). It is interesting to note, 
however, that long-term inhibition of PHD activity may lead to cardiomyopathy (Moslehi et 
al., 2010). This may relate to the adverse effects of prolonged Hif1 activation or to other 
targets regulated by PHDs. In this context, it was recently discovered that thyroid hormone 
receptor-α, a transcriptional regulator of many genes, is hydroxylated by PHD2/3 in the 
heart (Xie et al., 2015). The inhibition of PHD led to an increase in thyroid hormone 
receptor-α-dependent suppression of PLN gene expression, a sustained activation of 
CaMKII and a sensitization of mice to chronic β-adrenergic stress-induced myocardial injury 
(Xie et al., 2015).  
 Other targets of Nox-mediated redox signaling in the setting of acute and chronic 
cardiac stress have also been identified. The transcription factor Nrf2 (nuclear factor 
erythroid-derived 2-like 2) is a master regulator of a cytoprotective gene program that is 
activated in cardiac myocytes during acute neurohumoral stress or in the heart in vivo 
during chronic hemodynamic overload, settings in which Nox4 levels also increase. The 
upregulation of Nrf2 in these settings was found to be under the specific regulation of Nox4 
and Nrf2 contributed to the cardioprotective effects of Nox4 (Brewer et al. 2011; Smyrnias 
et al., 2015). Nox4 is also upregulated during protein unfolding stress in cardiac cells and we 
have recently identified that it boosts stress-induced phosphorylation of the eukaryotic 
initiation factor 2α (eIF2α) and the so-called integrated stress response via a very specific 
and localized redox inhibition of PP1 at the ER (Santos et al., 2016). PP1 inhibition by Nox4 
involves the oxidation of its metal center rather than cysteine oxidation (Santos et al., 2016). 
This Nox4-mediated enhancement of eIF2α signaling mediates cardioprotective effects by 
reducing myocardial infarct size during acute ischemia-reperfusion (Santos et al., 2016). 
Ischemic cardiac preconditioning is a phenomenon whereby transient exposure to ischemia 
induces protection against subsequent prolonged ischemia. Here, it has been found that 
Nox2-derived ROS can trigger ischemic cardiac preconditioning through protein kinase C 
activation (Bell et al., 2005; Kimura et al., 2005). 
 
13 
 
4. Associated pathologies and therapeutic implications 
While oxidative stress has been implicated in the pathophysiology of heart disease 
for several decades, only more recently have the role of redox signaling and specific 
molecular targets of such signaling become better appreciated. Among the specific 
molecular targets that can become redox-modified through specific post-translational 
modifications, a number (e.g. CaMKII and other kinases) may act as hubs in signaling 
networks through their ability to integrate different types of signals, e.g. Ca2+, cyclic 
nucleotide second messengers and ROS generated by specific enzymes. Specific ROS sources 
such as Nox2 and Nox4 may themselves integrate the effects of different stresses as a 
consequence of stress-induced activation or increase in abundance. Such redox hubs may be 
especially important in the context of heart failure. A striking observation is that redox 
circuits can mediate adaptive or detrimental effects, indicating one reason why non-specific 
“antioxidant” approaches have failed in heart disease and why it may be better to identify 
specific targets for therapeutic manipulation. Targets for inhibition may include Nox2 and 
CamKII, both of which appear to contribute to the development of heart failure, whereas 
the activation of other targets (e.g. Nox4-regulated pathways) might be beneficial. Several 
important challenges remain. We need to elucidate how different redox molecular 
mechanisms interact with other post-translational modifications, cell compartment-specific 
effects, the interplay among different ROS sources, and the integrated functioning of 
different signaling pathways under normal and stress condition. Better tools to monitor ROS 
production and action (e.g. probes for real-time detection of ROS at high spatial and 
temporal resolution) as well as systems biology approaches to elucidate integrated signaling 
will be valuable. Finally, more human data is required to provide clinical relevance and 
determine the potential for clinical translation.   
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FIGURE LEGENDS 
Fig. 1. Schematic showing stress-induced signalling cascades in the heart. The major stress 
stimuli that induce chronic adaptation of the heart are neurohumoral agonists, cytokines, 
growth factors, mechanical forces and hypoxia. Key kinases and enzymes that are redox-
sensitive include MAPKs, protein kinase C (PKC), protein kinase G (PKG), protein kinase A 
(PKA), Ca/calmodulin kinase II (CamKII) and HIF prolyl hydroxylases (PHD). Class II histone 
deacetylases (HDAC) can also be redox-modulated. These eventually affect the transcription 
of genes that contribute to hypertrophy, metabolic changes, cytoprotection, angiogenesis 
and other changes.  
 
Fig. 2. Acute redox-sensitive stress responses that affect cardiomyocyte excitation-
contraction coupling (ECC) and calcium homeostasis. Cardiomyocyte ECC involves Ca-
induced Ca release from the sarcoplasmic reticulum (SR) via Ryanodine receptors (RyR), to 
activate myofilaments. Ca is taken back into the SR via the SERCA pump, which is regulated 
by phospholamban (PLB). Other channels and pumps contributing to ECC include Na and K 
channels, the Na/Ca exchanger (NCX) and the sarcolemmal Ca ATPase. Beta-adrenergic 
stimulation is a major modulator of ECC through the cAMP/PKA-dependent phosphorylation 
of PLB, the L-type Ca channel and myofilaments. Redox modulation of PKA, PKG and CamKII 
as well as direct effects of ROS on the RyR synergise with the Ca-dependent and beta-
adrenergic regulation. 
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